Clinical trials: Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds
- Condition Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
No studies match all of these filters
Remove a filter, check the spelling of a condition or drug, or try a broader term: “lung cancer” rather than a subtype.